Asia Pacific Attention Deficit Hyperactivity Disorder Market Size, Share & Industry Trends Analysis Report By Drug Type, By Demographics (Adults and Children), By Distribution Channel (Retail Pharmacy and Hospital Pharmacy), By Country and Growth Forecast, 2022 - 2028

The Asia Pacific Attention Deficit Hyperactivity Disorder Market would witness market growth of 5.6% CAGR during the forecast period (2022-2028).

Studies using magnetic resonance imaging (MRI) reveal more significant cortical thinning and reduced volumes of the caudate, cerebellum, corpus callosum, and suitable frontal regions. Functional MRI results, including some studies of drug-naive patients, reveal distinctions in the functioning of the brain between controls and those with ADHD.

Adults with ADHD have impaired cerebral glucose metabolism in the premotor and prefrontal regions of the frontal lobe, according to positron emission tomography (PET). The immediate and noticeable reaction of ADHD signs to stimulant drugs like methylphenidate and amphetamines, which raise synaptic dopamine levels, raises the possibility that deficits in dopaminergic, catecholaminergic, and nicotinergic functioning are the primary underlying pathophysiological process.

Due to the widespread effects of ADHD, the condition is likely to have an adverse economic impact on kids, families, and society as a whole. The study of these financial implications has only recently begun, but preliminary research indicates that ADHD raises healthcare and other costs. A number of research studies have looked at the costs to families, the cost of criminal behavior among people with ADHD, the cost of prevalent medical and psychiatric comorbidities of ADHD.

In recent years, a rise in the number of individuals with ADHD has been observed in China. It has been estimated by extrapolating the data from several studies that the number of ADHD patients would increase further. The increased ADHD among school-aged children is also associated with mounting academic pressure. As a result of the increasing recognition of ADHD in the nation, many parents and teachers have reported a higher number of children with ADHD than there are. Additionally, in this region, it has also been seen that the prevalence of ADHD was higher in children belonging to low socioeconomic status backgrounds.

The China market dominated the Asia Pacific Attention Deficit Hyperactivity Disorder Market by Country in 2021; thereby, achieving a market value of $816.5 million by 2028. The Japan market is registering a CAGR of 4.9% during (2022 - 2028). Additionally, The India market would showcase a CAGR of 6.2% during (2022 - 2028).

Based on Drug Type, the market is segmented into Stimulants and Non-stimulants. Based on Stimulants Type, the market is segmented into Amphetamine, Methylphenidate, Lisdexamfetamine and Dexmethylphenidate. Based on Non-stimulants Type, the market is segmented into Atomoxetine, Guanfacine, Clonidine and Others. Based on Demographics, the market is segmented into Adults and Children. Based on Distribution Channel, the market is segmented into Retail Pharmacy and Hospital Pharmacy. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

Free Valuable Insights: The Worldwide Attention Deficit Hyperactivity Disorder Market is Projected to reach USD 16.9 Billion by 2028, at a CAGR of 4%

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Eli Lilly And Company, Pfizer, Inc. (Global Blood Therapeutics, Inc.), Johnson & Johnson (Johnson & Johnson Services, Inc.), Lupin Limited, Novartis AG, Takeda Pharmaceutical Company Limited, Mallinckrodt PLC, Purdue Pharma L.P., Aytu BioPharma, Inc. and Supernus Pharmaceuticals, Inc.

Scope of the Study

Market Segments Covered in the Report:

By Drug Type

• Stimulants
  • Amphetamine
  • Methylphenidate
  • Lisdexamfetamine
  • Dexmethylphenidate
• Non-stimulants
  • Atomoxetine
  • Guanfacine
  • Clonidine
  • Others

By Demographics

• Adults
• Children

By Distribution Channel

• Retail Pharmacy
• Hospital Pharmacy

By Country

• China
• Japan
• India
• South Korea
• Singapore
• Malaysia
• Rest of Asia Pacific

Key Market Players

List of Companies Profiled in the Report:

• Eli Lilly And Company
• Pfizer, Inc. (Global Blood Therapeutics, Inc.)
• Johnson & Johnson (Johnson & Johnson Services, Inc.)
• Lupin Limited
• Novartis AG
• Takeda Pharmaceutical Company Limited
• Mallinckrodt PLC
• Purdue Pharma L.P.
• Aytu BioPharma, Inc.
• Supernus Pharmaceuticals, Inc.

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Attention Deficit Hyperactivity Disorder Market, by Drug Type
1.4.2 Asia Pacific Attention Deficit Hyperactivity Disorder Market, by Demographics
1.4.3 Asia Pacific Attention Deficit Hyperactivity Disorder Market, by Distribution Channel
1.4.4 Asia Pacific Attention Deficit Hyperactivity Disorder Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Strategies deployed in Attention Deficit Hyperactivity Disorder Market

Chapter 4. Asia Pacific Attention Deficit Hyperactivity Disorder Market by Drug Type
4.1 Asia Pacific Stimulants Market by Country
4.2 Asia Pacific Attention Deficit Hyperactivity Disorder Market by Stimulants Type
4.2.1 Asia Pacific Amphetamine Market by Country
4.2.2 Asia Pacific Methylphenidate Market by Country
4.2.3 Asia Pacific Lisdexamfetamine Market by Country
4.2.4 Asia Pacific Dexmethylphenidate Market by Country
4.3 Asia Pacific Non-stimulants Market by Country
4.4 Asia Pacific Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type
4.4.1 Asia Pacific Atomoxetine Market by Country
4.4.2 Asia Pacific Guanfacine Market by Country
4.4.3 Asia Pacific Clonidine Market by Country
4.4.4 Asia Pacific Others Market by Country

Chapter 5. Asia Pacific Attention Deficit Hyperactivity Disorder Market by Demographics
5.1 Asia Pacific Adults Market by Country
5.2 Asia Pacific Children Market by Country

Chapter 6. Asia Pacific Attention Deficit Hyperactivity Disorder Market by Distribution Channel
6.1 Asia Pacific Retail Pharmacy Market by Country
6.2 Asia Pacific Hospital Pharmacy Market by Country

Chapter 7. Asia Pacific Attention Deficit Hyperactivity Disorder Market by Country
7.1 China Attention Deficit Hyperactivity Disorder Market
7.1.1 China Attention Deficit Hyperactivity Disorder Market by Drug Type
7.1.1.1 China Attention Deficit Hyperactivity Disorder Market by Stimulants Type
7.1.1.2 China Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type
7.1.2 China Attention Deficit Hyperactivity Disorder Market by Demographics
7.1.3 China Attention Deficit Hyperactivity Disorder Market by Distribution Channel
7.2 Japan Attention Deficit Hyperactivity Disorder Market
7.2.1 Japan Attention Deficit Hyperactivity Disorder Market by Drug Type
7.2.1.1 Japan Attention Deficit Hyperactivity Disorder Market by Stimulants Type
7.2.1.2 Japan Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type
7.2.2 Japan Attention Deficit Hyperactivity Disorder Market by Demographics
7.2.3 Japan Attention Deficit Hyperactivity Disorder Market by Distribution Channel
7.3 India Attention Deficit Hyperactivity Disorder Market
7.3.1 India Attention Deficit Hyperactivity Disorder Market by Drug Type
7.3.1.1 India Attention Deficit Hyperactivity Disorder Market by Stimulants Type
7.3.1.2 India Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type
7.3.2 India Attention Deficit Hyperactivity Disorder Market by Demographics
7.3.3 India Attention Deficit Hyperactivity Disorder Market by Distribution Channel
7.4 South Korea Attention Deficit Hyperactivity Disorder Market
7.4.1 South Korea Attention Deficit Hyperactivity Disorder Market by Drug Type
7.4.1.1 South Korea Attention Deficit Hyperactivity Disorder Market by Stimulants Type
7.4.1.2 South Korea Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type
7.4.2 South Korea Attention Deficit Hyperactivity Disorder Market by Demographics
7.4.3 South Korea Attention Deficit Hyperactivity Disorder Market by Distribution Channel
7.5 Singapore Attention Deficit Hyperactivity Disorder Market
7.5.1 Singapore Attention Deficit Hyperactivity Disorder Market by Drug Type
7.5.1.1 Singapore Attention Deficit Hyperactivity Disorder Market by Stimulants Type
7.5.1.2 Singapore Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type
7.5.2 Singapore Attention Deficit Hyperactivity Disorder Market by Demographics
7.5.3 Singapore Attention Deficit Hyperactivity Disorder Market by Distribution Channel
7.6 Malaysia Attention Deficit Hyperactivity Disorder Market
7.6.1 Malaysia Attention Deficit Hyperactivity Disorder Market by Drug Type
7.6.1.1 Malaysia Attention Deficit Hyperactivity Disorder Market by Stimulants Type
7.6.1.2 Malaysia Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type
7.6.2 Malaysia Attention Deficit Hyperactivity Disorder Market by Demographics
7.6.3 Malaysia Attention Deficit Hyperactivity Disorder Market by Distribution Channel
7.7 Rest of Asia Pacific Attention Deficit Hyperactivity Disorder Market
7.7.1 Rest of Asia Pacific Attention Deficit Hyperactivity Disorder Market by Drug Type
7.7.1.1 Rest of Asia Pacific Attention Deficit Hyperactivity Disorder Market by Stimulants Type
7.7.1.2 Rest of Asia Pacific Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type
7.7.2 Rest of Asia Pacific Attention Deficit Hyperactivity Disorder Market by Demographics
7.7.3 Rest of Asia Pacific Attention Deficit Hyperactivity Disorder Market by Distribution Channel

Chapter 8. Company Profiles
8.1 Eli Lilly And Company
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent strategies and developments:
8.1.5.1 Acquisition and Mergers:
8.2 Pfizer, Inc. (Global Blood Therapeutics, Inc.)
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Regional & Segmental Analysis
8.2.4 Research & Development Expense
8.4 Lupin Limited
8.4.1 Company Overview
8.4.2 Financial Analysis
8.5 Novartis AG
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.5.5 Recent strategies and developments:
8.5.5.1 Approvals and Trials:
8.6 Takeda Pharmaceutical Company Limited
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Regional Analysis
8.6.4 Research & Development Expense
8.7 Mallinckrodt PLC
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expense
8.8 Purdue Pharma L.P.
8.8.1 Company Overview
8.8.2 Recent strategies and developments:
8.8.2.1 Approvals and Trials:
8.9 Aytu BioPharma, Inc.
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expenses
8.9.5 Recent strategies and developments:
8.9.5.1 Product Launches and Product Expansions:
8.9.5.2 Approvals and Trials:
8.10. Supernus Pharmaceuticals, Inc.
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Research & Development Expenses
8.10.4 Recent strategies and developments:
8.10.4.1 Approvals and Trials:

TABLE 1 Asia Pacific Attention Deficit Hyperactivity Disorder Market, 2018 - 2021, USD Million
TABLE 2 Asia Pacific Attention Deficit Hyperactivity Disorder Market, 2022 - 2028, USD Million
TABLE 3 Asia Pacific Attention Deficit Hyperactivity Disorder Market by Drug Type, 2018 - 2021, USD Million
TABLE 4 Asia Pacific Attention Deficit Hyperactivity Disorder Market by Drug Type, 2022 - 2028, USD Million
TABLE 5 Asia Pacific Stimulants Market by Country, 2018 - 2021, USD Million
TABLE 6 Asia Pacific Stimulants Market by Country, 2022 - 2028, USD Million
TABLE 7 Asia Pacific Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2018 - 2021, USD Million
TABLE 8 Asia Pacific Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2022 - 2028, USD Million
TABLE 9 Asia Pacific Amphetamine Market by Country, 2018 - 2021, USD Million
TABLE 10 Asia Pacific Amphetamine Market by Country, 2022 - 2028, USD Million
TABLE 11 Asia Pacific Methylphenidate Market by Country, 2018 - 2021, USD Million
TABLE 12 Asia Pacific Methylphenidate Market by Country, 2022 - 2028, USD Million
TABLE 13 Asia Pacific Lisdexamfetamine Market by Country, 2018 - 2021, USD Million
TABLE 14 Asia Pacific Lisdexamfetamine Market by Country, 2022 - 2028, USD Million
TABLE 15 Asia Pacific Dexmethylphenidate Market by Country, 2018 - 2021, USD Million
TABLE 16 Asia Pacific Dexmethylphenidate Market by Country, 2022 - 2028, USD Million
TABLE 17 Asia Pacific Non-stimulants Market by Country, 2018 - 2021, USD Million
TABLE 18 Asia Pacific Non-stimulants Market by Country, 2022 - 2028, USD Million
TABLE 19 Asia Pacific Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2018 - 2021, USD Million
TABLE 20 Asia Pacific Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2022 - 2028, USD Million
TABLE 21 Asia Pacific Atomoxetine Market by Country, 2018 - 2021, USD Million
TABLE 22 Asia Pacific Atomoxetine Market by Country, 2022 - 2028, USD Million
TABLE 23 Asia Pacific Guanfacine Market by Country, 2018 - 2021, USD Million
TABLE 24 Asia Pacific Guanfacine Market by Country, 2022 - 2028, USD Million
TABLE 25 Asia Pacific Clonidine Market by Country, 2018 - 2021, USD Million
TABLE 26 Asia Pacific Clonidine Market by Country, 2022 - 2028, USD Million
TABLE 27 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
TABLE 28 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
TABLE 29 Asia Pacific Attention Deficit Hyperactivity Disorder Market by Demographics, 2018 - 2021, USD Million
TABLE 30 Asia Pacific Attention Deficit Hyperactivity Disorder Market by Demographics, 2022 - 2028, USD Million
TABLE 31 Asia Pacific Adults Market by Country, 2018 - 2021, USD Million
TABLE 32 Asia Pacific Adults Market by Country, 2022 - 2028, USD Million
TABLE 33 Asia Pacific Children Market by Country, 2018 - 2021, USD Million
TABLE 34 Asia Pacific Children Market by Country, 2022 - 2028, USD Million
TABLE 35 Asia Pacific Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 36 Asia Pacific Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 37 Asia Pacific Retail Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 38 Asia Pacific Retail Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 39 Asia Pacific Hospital Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 40 Asia Pacific Hospital Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 41 Asia Pacific Attention Deficit Hyperactivity Disorder Market by Country, 2018 - 2021, USD Million
TABLE 42 Asia Pacific Attention Deficit Hyperactivity Disorder Market by Country, 2022 - 2028, USD Million
TABLE 43 China Attention Deficit Hyperactivity Disorder Market, 2018 - 2021, USD Million
TABLE 44 China Attention Deficit Hyperactivity Disorder Market, 2022 - 2028, USD Million
TABLE 45 China Attention Deficit Hyperactivity Disorder Market by Drug Type, 2018 - 2021, USD Million
TABLE 46 China Attention Deficit Hyperactivity Disorder Market by Drug Type, 2022 - 2028, USD Million
TABLE 47 China Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2018 - 2021, USD Million
TABLE 48 China Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2022 - 2028, USD Million
TABLE 49 China Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2018 - 2021, USD Million
TABLE 50 China Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2022 - 2028, USD Million
TABLE 51 China Attention Deficit Hyperactivity Disorder Market by Demographics, 2018 - 2021, USD Million
TABLE 52 China Attention Deficit Hyperactivity Disorder Market by Demographics, 2022 - 2028, USD Million
TABLE 53 China Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 54 China Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 55 Japan Attention Deficit Hyperactivity Disorder Market, 2018 - 2021, USD Million
TABLE 56 Japan Attention Deficit Hyperactivity Disorder Market, 2022 - 2028, USD Million
TABLE 57 Japan Attention Deficit Hyperactivity Disorder Market by Drug Type, 2018 - 2021, USD Million
TABLE 58 Japan Attention Deficit Hyperactivity Disorder Market by Drug Type, 2022 - 2028, USD Million
TABLE 59 Japan Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2018 - 2021, USD Million
TABLE 60 Japan Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2022 - 2028, USD Million
TABLE 61 Japan Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2018 - 2021, USD Million
TABLE 62 Japan Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2022 - 2028, USD Million
TABLE 63 Japan Attention Deficit Hyperactivity Disorder Market by Demographics, 2018 - 2021, USD Million
TABLE 64 Japan Attention Deficit Hyperactivity Disorder Market by Demographics, 2022 - 2028, USD Million
TABLE 65 Japan Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 66 Japan Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 67 India Attention Deficit Hyperactivity Disorder Market, 2018 - 2021, USD Million
TABLE 68 India Attention Deficit Hyperactivity Disorder Market, 2022 - 2028, USD Million
TABLE 69 India Attention Deficit Hyperactivity Disorder Market by Drug Type, 2018 - 2021, USD Million
TABLE 70 India Attention Deficit Hyperactivity Disorder Market by Drug Type, 2022 - 2028, USD Million
TABLE 71 India Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2018 - 2021, USD Million
TABLE 72 India Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2022 - 2028, USD Million
TABLE 73 India Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2018 - 2021, USD Million
TABLE 74 India Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2022 - 2028, USD Million
TABLE 75 India Attention Deficit Hyperactivity Disorder Market by Demographics, 2018 - 2021, USD Million
TABLE 76 India Attention Deficit Hyperactivity Disorder Market by Demographics, 2022 - 2028, USD Million
TABLE 77 India Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 78 India Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 79 South Korea Attention Deficit Hyperactivity Disorder Market, 2018 - 2021, USD Million
TABLE 80 South Korea Attention Deficit Hyperactivity Disorder Market, 2022 - 2028, USD Million
TABLE 81 South Korea Attention Deficit Hyperactivity Disorder Market by Drug Type, 2018 - 2021, USD Million
TABLE 82 South Korea Attention Deficit Hyperactivity Disorder Market by Drug Type, 2022 - 2028, USD Million
TABLE 83 South Korea Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2018 - 2021, USD Million
TABLE 84 South Korea Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2022 - 2028, USD Million
TABLE 85 South Korea Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2018 - 2021, USD Million
TABLE 86 South Korea Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2022 - 2028, USD Million
TABLE 87 South Korea Attention Deficit Hyperactivity Disorder Market by Demographics, 2018 - 2021, USD Million
TABLE 88 South Korea Attention Deficit Hyperactivity Disorder Market by Demographics, 2022 - 2028, USD Million
TABLE 89 South Korea Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 90 South Korea Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 91 Singapore Attention Deficit Hyperactivity Disorder Market, 2018 - 2021, USD Million
TABLE 92 Singapore Attention Deficit Hyperactivity Disorder Market, 2022 - 2028, USD Million
TABLE 93 Singapore Attention Deficit Hyperactivity Disorder Market by Drug Type, 2018 - 2021, USD Million
TABLE 94 Singapore Attention Deficit Hyperactivity Disorder Market by Drug Type, 2022 - 2028, USD Million
TABLE 95 Singapore Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2018 - 2021, USD Million
TABLE 96 Singapore Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2022 - 2028, USD Million
TABLE 97 Singapore Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2018 - 2021, USD Million
TABLE 98 Singapore Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2022 - 2028, USD Million
TABLE 99 Singapore Attention Deficit Hyperactivity Disorder Market by Demographics, 2018 - 2021, USD Million
TABLE 100 Singapore Attention Deficit Hyperactivity Disorder Market by Demographics, 2022 - 2028, USD Million
TABLE 101 Singapore Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 102 Singapore Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 103 Malaysia Attention Deficit Hyperactivity Disorder Market, 2018 - 2021, USD Million
TABLE 104 Malaysia Attention Deficit Hyperactivity Disorder Market, 2022 - 2028, USD Million
TABLE 105 Malaysia Attention Deficit Hyperactivity Disorder Market by Drug Type, 2018 - 2021, USD Million
TABLE 106 Malaysia Attention Deficit Hyperactivity Disorder Market by Drug Type, 2022 - 2028, USD Million
TABLE 107 Malaysia Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2018 - 2021, USD Million
TABLE 108 Malaysia Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2022 - 2028, USD Million
TABLE 109 Malaysia Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2018 - 2021, USD Million
TABLE 110 Malaysia Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2022 - 2028, USD Million
TABLE 111 Malaysia Attention Deficit Hyperactivity Disorder Market by Demographics, 2018 - 2021, USD Million
TABLE 112 Malaysia Attention Deficit Hyperactivity Disorder Market by Demographics, 2022 - 2028, USD Million
TABLE 113 Malaysia Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 114 Malaysia Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 115 Rest of Asia Pacific Attention Deficit Hyperactivity Disorder Market, 2018 - 2021, USD Million
TABLE 116 Rest of Asia Pacific Attention Deficit Hyperactivity Disorder Market, 2022 - 2028, USD Million
TABLE 117 Rest of Asia Pacific Attention Deficit Hyperactivity Disorder Market by Drug Type, 2018 - 2021, USD Million
TABLE 118 Rest of Asia Pacific Attention Deficit Hyperactivity Disorder Market by Drug Type, 2022 - 2028, USD Million
TABLE 119 Rest of Asia Pacific Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2018 - 2021, USD Million
TABLE 120 Rest of Asia Pacific Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2022 - 2028, USD Million
TABLE 121 Rest of Asia Pacific Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2018 - 2021, USD Million
TABLE 122 Rest of Asia Pacific Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2022 - 2028, USD Million
TABLE 123 Rest of Asia Pacific Attention Deficit Hyperactivity Disorder Market by Demographics, 2018 - 2021, USD Million
TABLE 124 Rest of Asia Pacific Attention Deficit Hyperactivity Disorder Market by Demographics, 2022 - 2028, USD Million
TABLE 125 Rest of Asia Pacific Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 126 Rest of Asia Pacific Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 127 Key Information – Eli Lilly And Company
TABLE 128 Key Information – Pfizer, Inc.
TABLE 129 Key Information – Johnson & Johnson (Johnson & Johnson Services, Inc.)
TABLE 130 Key Information – Lupin Limited
TABLE 131 Key Information – Novartis AG
TABLE 132 Key Information – Takeda Pharmaceutical Company Limited
TABLE 133 Key information – Mallinckrodt PLC
TABLE 134 Key Information – Purdue Pharma L.P.
TABLE 135 Key Information – AYTU BIOPHARMA, INC.
TABLE 136 Key Information – Supernus Pharmaceuticals, Inc.

List of Figures
FIG 1 Methodology for the research